Antibiotics Covering Staph and Strep
For most skin and soft tissue infections caused by Staphylococcus aureus and Streptococcus pyogenes, use amoxicillin-clavulanate, cephalexin, or dicloxacillin as first-line oral agents, and nafcillin/oxacillin or cefazolin for intravenous therapy when treating methicillin-susceptible strains. 1, 2
Oral Antibiotic Options
For mild infections requiring oral therapy:
- Amoxicillin-clavulanate: 875/125 mg twice daily (adults) or 25 mg/kg/day divided twice daily (children) - provides excellent dual coverage 1, 2
- Cephalexin: 500 mg four times daily (adults) or 25-50 mg/kg/day in 3-4 divided doses (children) - first-choice agent per WHO guidelines 1, 2
- Dicloxacillin: 500 mg four times daily (adults) or 25-50 mg/kg/day in 4 divided doses (children) - oral agent of choice for MSSA in adults 1
- Clindamycin: 300-400 mg four times daily (adults) or 20 mg/kg/day in 3 divided doses (children) - covers both pathogens but has inducible resistance concerns 1
Intravenous Antibiotic Options
For moderate to severe infections requiring parenteral therapy:
- Nafcillin or oxacillin: 1-2 g every 4 hours IV (adults) or 100-150 mg/kg/day in 4 divided doses (children) - parenteral drug of choice for MSSA 1
- Cefazolin: 1 g every 8 hours IV (adults) or 50 mg/kg/day in 3 divided doses (children) - more convenient than nafcillin with less bone marrow suppression, appropriate for penicillin-allergic patients except those with immediate hypersensitivity 1
MRSA Considerations
If methicillin-resistant S. aureus is suspected or confirmed, coverage must be adjusted:
- Oral options: Trimethoprim-sulfamethoxazole (1-2 double-strength tablets twice daily), doxycycline (100 mg twice daily), or clindamycin 1
- IV options: Vancomycin (30 mg/kg/day in 2 divided doses for adults, 40 mg/kg/day in 4 divided doses for children), linezolid (600 mg every 12 hours), or daptomycin (4 mg/kg every 24 hours) 1
Topical Therapy for Limited Disease
For localized impetigo with limited lesions:
- Mupirocin 2% ointment: Apply twice daily - highly effective with 99.2% therapeutic response rate 1, 3, 4
- Retapamulin 1% ointment: Apply twice daily - alternative topical option 1, 3
Critical Clinical Pitfalls
Avoid monotherapy with erythromycin or macrolides - resistance rates are significant in both S. aureus and S. pyogenes strains 1. Clindamycin carries risk of inducible resistance in erythromycin-resistant strains, particularly with MRSA 1.
For necrotizing fasciitis caused by S. pyogenes, the specific recommendation is penicillin plus clindamycin, as clindamycin inhibits toxin production even when bacterial growth stops 1. This combination addresses the high mortality (30-70%) associated with streptococcal necrotizing infections 1.
Trimethoprim-sulfamethoxazole has poor streptococcal coverage - while effective against staphylococci, it should not be relied upon as monotherapy when streptococcal infection is likely 1.